EP0800531A4 - Novel receptor tyrosine kinases - Google Patents

Novel receptor tyrosine kinases

Info

Publication number
EP0800531A4
EP0800531A4 EP95943567A EP95943567A EP0800531A4 EP 0800531 A4 EP0800531 A4 EP 0800531A4 EP 95943567 A EP95943567 A EP 95943567A EP 95943567 A EP95943567 A EP 95943567A EP 0800531 A4 EP0800531 A4 EP 0800531A4
Authority
EP
European Patent Office
Prior art keywords
receptor tyrosine
tyrosine kinases
novel receptor
novel
kinases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95943567A
Other languages
German (de)
French (fr)
Other versions
EP0800531A2 (en
Inventor
Alastair Reith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ludwig Institute for Cancer Research Ltd
Ludwig Institute for Cancer Research New York
Original Assignee
Ludwig Institute for Cancer Research Ltd
Ludwig Institute for Cancer Research New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9420389A external-priority patent/GB9420389D0/en
Priority claimed from GBGB9510574.8A external-priority patent/GB9510574D0/en
Application filed by Ludwig Institute for Cancer Research Ltd, Ludwig Institute for Cancer Research New York filed Critical Ludwig Institute for Cancer Research Ltd
Publication of EP0800531A2 publication Critical patent/EP0800531A2/en
Publication of EP0800531A4 publication Critical patent/EP0800531A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4716—Muscle proteins, e.g. myosin, actin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
EP95943567A 1994-10-10 1995-10-10 Novel receptor tyrosine kinases Withdrawn EP0800531A4 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9420389A GB9420389D0 (en) 1994-10-10 1994-10-10 Novel receptor tyrosine kinase
GB9420389 1994-10-10
GB9510574 1995-05-24
GBGB9510574.8A GB9510574D0 (en) 1995-05-24 1995-05-24 Novel receptor tyrosine kinases
PCT/US1995/013490 WO1996011664A2 (en) 1994-10-10 1995-10-10 Nsk2 a muscle receptor tyrosine kinase

Publications (2)

Publication Number Publication Date
EP0800531A2 EP0800531A2 (en) 1997-10-15
EP0800531A4 true EP0800531A4 (en) 1999-09-22

Family

ID=26305770

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95943567A Withdrawn EP0800531A4 (en) 1994-10-10 1995-10-10 Novel receptor tyrosine kinases

Country Status (4)

Country Link
EP (1) EP0800531A4 (en)
JP (1) JP2002517166A (en)
AU (1) AU4500696A (en)
WO (1) WO1996011664A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5681714A (en) * 1992-07-30 1997-10-28 Mount Sinai Hospital Corporation Nucleic acid encoding tek receptor tyrosine kinase
US6028053A (en) * 1995-10-27 2000-02-22 Mount Sinai Hospital Corporation Peptide inhibitors of a phosphotyrosine-binding domain containing protein
EP0874639A4 (en) * 1995-10-27 1999-07-28 Mount Sinai Hospital Corp Peptide inhibitors of a phosphotyrosine-binding domain containing protein

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996002643A1 (en) * 1994-07-20 1996-02-01 Regeneron Pharmaceuticals, Inc. Denervated muscle kinase (dmk), a receptor of the tyrosine kinase super family
WO1996002644A1 (en) * 1994-07-20 1996-02-01 Genetics Institute, Inc. Mlk receptor tyrosine kinases

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996002643A1 (en) * 1994-07-20 1996-02-01 Regeneron Pharmaceuticals, Inc. Denervated muscle kinase (dmk), a receptor of the tyrosine kinase super family
WO1996002644A1 (en) * 1994-07-20 1996-02-01 Genetics Institute, Inc. Mlk receptor tyrosine kinases

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
See also references of WO9611664A3 *
VALENZUELA D.M. ET AL.: "Receptor tyrosine kinase specific for the skeletal muscle lineage: expression in embryonic muscle, at the neuromuscular junction, and after injury", NEURON, vol. 15, no. 3, September 1995 (1995-09-01), pages 573 - 584, XP000674260 *

Also Published As

Publication number Publication date
EP0800531A2 (en) 1997-10-15
WO1996011664A3 (en) 1996-07-04
AU4500696A (en) 1996-05-06
JP2002517166A (en) 2002-06-11
WO1996011664A2 (en) 1996-04-25

Similar Documents

Publication Publication Date Title
ZA9610725B (en) Tyrosine derivatives
IL107661A0 (en) Her4 human receptor tyrosine kinase
HU9603525D0 (en) Vironectin receptor antagonists
HU9601529D0 (en) Pyrimidinedion-, pyrimidinetrion-, triazinedion-, tetrahydro-quinazolinedion- derivatives as alpha-adrenerg receptor antagonists
GB9416554D0 (en) Glutamate receptor
GB9517098D0 (en) Receptor
GB9617923D0 (en) Novel receptor
EP0973800A4 (en) Novel receptor
ZA945372B (en) Tyrosine kinase receptor
EP0800531A4 (en) Novel receptor tyrosine kinases
EP0792282A4 (en) Human endothelin-bombesin receptor
IL115642A0 (en) Her4 human receptor tyrosine kinase
EP0773959A4 (en) Adrenergic receptor
AU2963395A (en) Mlk receptor tyrosine kinases
GB9510574D0 (en) Novel receptor tyrosine kinases
GB9420389D0 (en) Novel receptor tyrosine kinase
GB9425502D0 (en) Novel receptor
GB9707776D0 (en) Adjustable bed
IL110384A0 (en) Tyrosine kinase receptor
AU5095298A (en) Novel receptor tyrosine kinases
GB9414997D0 (en) Receptor cloning
AU1120895A (en) Novel receptor tyrosine kinase
GB9718418D0 (en) Adjustable coupling
GB9403561D0 (en) Novel receptor
PL105794U1 (en) Pox

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19970422

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

A4 Supplementary search report drawn up and despatched

Effective date: 19990810

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

18W Application withdrawn

Withdrawal date: 19990823